Medtronic Spinal & Biologics

Medtronic Spinal & Biologics is a key division of Medtronic plc, a leading global medical device company. This segment is a major player in the spinal market, holding approximately 35% of the global share. Medtronic Spinal & Biologics focuses on developing and manufacturing advanced spinal implants, biologics, and enabling technologies that enhance spine surgery and musculoskeletal care. The product portfolio includes spinal implants like expandable titanium cages, biologics that promote bone growth, and enabling technologies such as imaging and navigation systems, robotics, and data science tools. These innovations support minimally invasive surgery solutions, which aim to reduce recovery times and improve surgical outcomes. Medtronic serves surgeons, hospitals, and healthcare providers, providing integrated solutions that enhance surgical precision and patient care. With a commitment to research and development, Medtronic continues to lead in the spinal and biologics market, generating significant revenue and expanding its offerings globally.

• Employees 190